Last updated: 2026-10-06 23:52:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $254,82, with a market capitalisation of $617,01B and a P/E ratio of 28,97. Over the past 52 weeks, its price has ranged from $182,94 to $281,07. This page covers its latest market performance, valuation, price trends and company information.
$617,01B | |
$254,15 | |
$281,07 | |
$46,25 | |
$252,93 | |
3,87M | |
7,06M | |
28,97 | |
$281,07 | |
$182,94 | |
2,07% | |
-- |
Johnson & Johnson (JNJ) is trading at $254,88 in after-hours trading as of 2026-10-06 23:50:00, up 0,77% ($1,94) from the regular-session close of $252,93.
After-hours trading shows how investors are pricing JNJ after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $271,22 to $254,82, representing a decline of 6,05% ($16,40).
The stock traded between $251,22 and $273,78 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 7,50 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 73,2%
JNJ is currently trading at $254,82, placing it 73,2% of the way from its 52-week low of $182,94 to its 52-week high of $281,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.